In the SURMOUNT-1 trial, tirzepatide at the highest dose (15 mg) produced average weight loss of 22.5% versus approximately 15% for semaglutide in comparable trials
Targets health-conscious consumers seeking functional beverage development and evidence-based wellness drinks
An epidemiologic study by Apnimed, a clinical-stage pharmaceutical company developing AD109, an oral drug candidate for OSA, demonstrated that most people with OSA60.6%are not obese
After the introductory two months, patients will transition to a newly lowered self-pay monthly price of $349 , reduced from $499 , marking an additional permanent cut
Demand is expected to be driven by specialist access constraints and consumer convenience
They are the leading manufacturer of digital indirect bonding trays, with more than 30,000 cases produced to date